Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -554 | -1,865 | -1,486 | -1,146 | -478 |
| Depreciation Amortization | 8 | -142 | 17 | 10 | 2 |
| Accounts receivable | 3 | N/A | -6 | -5 | -504 |
| Other Working Capital | 74 | 438 | 218 | 176 | -331 |
| Other Operating Activity | 88 | 307 | 185 | 129 | 567 |
| Operating Cash Flow | $-382 | $-1,262 | $-1,072 | $-835 | $-745 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -11 | -6 | N/A | N/A |
| Investing Cash Flow | $-2 | $-11 | $-6 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 100 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $100 | $0 | $0 | $0 | $0 |
| Beginning Cash Position | 561 | 1,834 | 1,834 | 1,834 | 1,834 |
| End Cash Position | 277 | 561 | 756 | 999 | 1,089 |
| Net Cash Flow | $-284 | $-1,273 | $-1,078 | $-834 | $-745 |
| Free Cash Flow | |||||
| Operating Cash Flow | -382 | -1,262 | -1,072 | -835 | -745 |
| Capital Expenditure | -2 | -11 | -6 | N/A | N/A |
| Free Cash Flow | -384 | -1,273 | -1,078 | -835 | -745 |